Testosterone treatment attenuates the effects of facial nerve transection on glial fibrillary acidic protein (GFAP) levels in the hamster facial motor nucleus.

Coers, Susanna; Tanzer, Lisa; Jones, Kathryn J

Coers, Susanna; Tanzer, Lisa; Jones, Kathryn J.

Affiliation

Coers S; Department of Cell Biology, Neurobiology, and Anatomy, Stritch School of Medicine, Loyola University of Chicago, Maywood, Illinois 60153, USA. scoers@lumc.edu

Metab Brain Dis ; 17(2): 55-63, 2002 Jun.

Article in En | MEDLINE | ID: mdl-12083337

Subject(s)

Facial Nerve Injuries/drug therapy; Facial Nerve/drug effects; Glial Fibrillary Acidic Protein/drug effects; Motor Neurons/drug effects; Neuroprotective Agents/pharmacology; Retrograde Degeneration/drug therapy; Testosterone/pharmacology; Animals; Astrocytes/drug effects; Astrocytes/metabolism; Cricetinae; Facial Nerve/pathology; Facial Nerve/physiopathology; Facial Nerve Injuries/metabolism; Facial Nerve Injuries/physiopathology; Gene Expression/drug effects; Gene Expression/physiology; Glial Fibrillary Acidic Protein/metabolism; Gliosis/drug therapy; Gliosis/metabolism; Gliosis/physiopathology; Male; Motor Neurons/metabolism; Motor Neurons/pathology; Retrograde Degeneration/metabolism; Retrograde Degeneration/physiopathology; Testosterone/metabolism; Up-Regulation/drug effects; Up-Regulation/physiology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Retrograde Degeneration / Testosterone / Neuroprotective Agents / Facial Nerve Injuries / Facial Nerve / Glial Fibrillary Acidic Protein / Motor Neurons Limits: Animals Language: En Journal: Metab Brain Dis Journal subject: CEREBRO / METABOLISMO Year: 2002 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links